Similar articles

• DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.

  Lemaire O, Attal M, Bourin P, Laroche M. Lemaire O, et al. Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5. Eur J Haematol. 2010. PMID: 19891699 No abstract available.
• Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.

  Dasanu CA, Reale MA, Bauer F. Dasanu CA, et al. Leuk Res. 2010 Jul;34(7):e178-80. doi: 10.1016/j.leukres.2010.01.002. Epub 2010 Jan 15. Leuk Res. 2010. PMID: 20079532 No abstract available.
• Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.

  Witzens-Harig M, Waldherr R, Beimler J, Zeier M, Hansmann J, Ho AD, Goldschmidt H, Moehler T. Witzens-Harig M, et al. Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29. Ann Hematol. 2007. PMID: 17605010 No abstract available.
• [Hematopoietic stem cell transplantation for multiple myeloma].

  Kanda Y. Kanda Y. Rinsho Ketsueki. 2009 Oct;50(10):1420-6. Rinsho Ketsueki. 2009. PMID: 19915350 Review. Japanese. No abstract available.
• Achieving an early myeloma response in patients with kidney impairment.

  Stringer S, Cook M, Cockwell P. Stringer S, et al. Adv Chronic Kidney Dis. 2012 Sep;19(5):303-11. doi: 10.1053/j.ackd.2012.07.005. Adv Chronic Kidney Dis. 2012. PMID: 22920641 Review.